XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
 3 Months Ended 6 Months Ended
Jul. 01, 2017
Jun. 25, 2016
Jul. 01, 2017
Jun. 25, 2016
Revenues:        
Net product revenues $ 4,979,400 $ 4,096,529 $ 8,912,543 $ 10,074,663
Research and development revenues 948,069 258,746 1,393,054 399,750
Total revenues 5,927,469 4,355,275 10,305,597 10,474,413
Expenses:        
Cost of product revenues 4,117,226 4,646,846 7,234,583 9,282,887
Research and development 4,678,221 4,119,401 8,960,090 8,159,352
Selling, general and administration 5,200,261 4,282,264 10,841,947 8,043,113
Gain on sale of property and plant 0 (7,700,522) 0 (7,700,522)
Total expenses 13,995,708 5,347,989 27,036,620 17,784,830
Loss from operations (8,068,239) (992,714) (16,731,023) (7,310,417)
Other income and expense:        
Interest income 186,142 175,765 419,919 340,713
Other income (expense), net 65,018 (119,282) 325,430 (158,374)
Foreign currency transaction gains (losses) 556,539 44,503 (634,743) (457,437)
Gain on investments 0 0 274,000 0
Total other income and expense 807,699 100,986 384,606 (275,098)
Loss before benefit (provision) for income taxes and net (income) loss attributable to noncontrolling interest (7,260,540) (891,728) (16,346,417) (7,585,515)
Tax benefit (provision) 0 (1,963,000) 1,146,000 (2,104,000)
Net loss (7,260,540) (2,854,728) (15,200,417) (9,689,515)
Net (income) loss attributable to the noncontrolling interest (71,431) (339,374) 10,007 (438,047)
Net loss attributable to the controlling interest $ (7,331,971) $ (3,194,102) $ (15,190,410) $ (10,127,562)
Net (loss) income per share        
Basic and diluted (usd per share) $ (0.10) $ (0.05) $ (0.22) $ (0.16)
Weighted average number of common shares        
Basic and diluted (in shares) 70,626,542 64,011,571 67,582,615 63,994,809